Post-approval studies (Phase 4)Ended earlyNCT00409526
What this trial is testing
Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
Who this might be right for
Pulmonary Hypertension
University of Chicago 1